Abstract:C 45 H 33 Cl 2 F 3 N 4 , monoclinic, P 2 1 / c (no. 14), a = 11.7076(13) Å, b = 11.8186(13) Å, c = 27.473(3) Å, β = 91.188(2)°, V = 3800.6(7) Å 3 , Z = 4, R gt ( F ) = 0.0591, wR ref ( F 2 ) = 0.1856, T = 293 K.
What problem does this paper attempt to address?
The paper mainly addresses the following issues:
### Research Background and Objectives
- **Research Subject**: The paper studies a novel pyridine dimer compound—4,8a-bis(4-chlorophenyl)-1,5,6-tris(4-fluorobenzyl)-1,4,4a,4b,5,6,8a,8b-octahydrocyclobuta[1,2-b:3,4-c']dipyridine-3,8-dicarbonitrile (chemical formula: C45H33Cl2F3N4).
- **Synthesis Method**: The novel pyridine dimer compound was synthesized by inducing the dihydropyridine framework through ultraviolet irradiation.
### Main Contributions
- **Structural Analysis**: The crystal structure of the compound was resolved using X-ray single-crystal diffraction technology, providing detailed crystallographic data, including molecular structure diagrams, atomic coordinates, and displacement parameters.
- **Potential Applications**: The paper mentions that pyridine dimer compounds have significant medical application prospects, such as serving as anticancer drugs that may achieve antitumor effects by interfering with cell cycle regulation or inducing apoptosis. Additionally, they may also serve as precursors for antibiotics, anti-inflammatory drugs, and antiviral drugs.
### Conclusion
In summary, the main objective of this paper is to synthesize and characterize a new pyridine dimer compound and explore its potential application value in the biomedical field. By conducting a detailed analysis of the compound's structure, the study lays the foundation for further exploration of its biological activity and pharmacological effects.